Tang Capital Management »

Atara Biotherapeutics shares owned by Tang Capital Management

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $639k 75k 8.50

More positions owned by Tang Capital Management

Tarsus Pharmaceuticals (TARS)
Evolus (EOLS)
Kalvista Pharmaceuticals (KALV)
Mirum Pharmaceuticals (MIRM)
Anaptysbio Inc Common (ANAB)
Biosante Pharmaceuticals (ANIP)
Dynavax Technologies Corp Com New (DVAX)
Eli Lilly & Co. (LLY)
ACADIA Pharmaceuticals (ACAD)
Vaxcyte (PCVX)
Ptc Therapeutics I (PTCT)
Intra Cellular Therapies (ITCI)
Altimmune Com New (ALT)
Miragen Therapeutics (VRDN)
Avadel Pharmaceuticals Com Shs (AVDL)

View all positions for Tang Capital Management

Top funds holding Atara Biotherapeutics

Redmile Group
EcoR1 Capital
Citadel Advisors
Bank of America Corporation
Vanguard Group
Centiva Capital
Acadian Asset Management
Millennium Management
Vestal Point Capital
Qube Research & Technologies
Tang Capital Management
Woodline Partners
BlackRock
Geode Capital Management
Renaissance Technologies

View all funds holding Atara Biotherapeutics